Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features
Current Oncology · 2025
DOI: 10.3390/curroncol32110633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Qin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Otorhinolaryngology Head and Neck Surgery, The 6th Medical Center of Chinese PLA General Hospital, Beijing 100853, China. Hauptthemen laut MEDLINE: Ear Neoplasms, Endolymphatic Sac, von Hippel-Lindau Disease. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation.
Abstract (Originalsprache)
Von Hippel–Lindau disease-associated endolymphatic sac tumors (VHL-associated ELSTs) present diagnostic challenges due to their rarity and nonspecific symptoms. This study describes clinical, pathological and genotypic features to guide treatment. We retrospectively analyzed seven patients with VHL-associated ELSTs. The mean age of otologic symptom [hearing loss (100%) and facial nerve paralysis (85.71%)] onset was 22.43 ± 8.68 years (range: 10–33). Surgical management included trans-labyrinthine and subtotal temporal bone resection approaches. Among three patients with severe preoperative facial nerve dysfunction, two underwent great auricular nerve grafting improved to House–Brackmann grade IV, while one receiving hypoglossal–facial nerve anastomosis reached grade V. Genetic testing identified pathogenic VHL gene missense mutations in three patients. Two female patients demonstrated disease progression during pregnancy. Literature analysis revealed exon-specific patterns: Exon 1 mutations correlated with cerebellar/spinal hemangioblastomas in female patients, while Exon 3 mutations were associated with multisystem tumors. These findings support that VHL-associated ELSTs manifest early with otologic symptoms and demonstrate exon-specific phenotypic patterns. Optimal management requires complete surgical resection, genetic diagnosis, and a multidisciplinary approach to address these complex tumors and achieve favorable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Department of Otorhinolaryngology Head and Neck Surgery, The 6th Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
- State Key Laboratory of Hearing and Balance Science, Beijing 100853, China.
- National Clinical Research Center for Otorhinolaryngologic Diseases, Beijing 100853, China.
- State Key Laboratory of Hearing Science, Ministry of Education, Beijing 100853, China.
- Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing 100853, China.
ORCID-Profile: Qin Wang, Zhikai Zhao
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Wang, Q., Huang, J., Zhao, Z., Su, Y., Wu, N., Yang, S., Shen, W., Sai, N., & Han, W. (2025). Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features. Current Oncology. https://doi.org/10.3390/curroncol32110633
Vancouver
Wang Q, Huang J, Zhao Z, Su Y, Wu N, Yang S, et al. Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features. Current Oncology. 2025. doi:10.3390/curroncol32110633
BibTeX
@article{Wang2025,
author = {Wang, Qin and Huang, Junhui and Zhao, Zhikai and Su, Yu and Wu, Nan and Yang, Shiming and Shen, Weidong and Sai, Na and Han, Weiju},
title = {Von Hippel–Lindau Disease-Associated Endolymphatic Sac Tumours: Seven Cases and Genotype–Phenotype Features},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32110633}
}
EUVIMED